"Advancing Precision Medicine: Oligonucleotide and Genome Editing Therapeutics"

Join us for a special IRM Stem Cell Seminar featuring Laura Sepp-Lorenzino, PhD, Scientific Advisor, Executive Vice President, and former Chief Scientific Officer at Intellia Therapeutics — a leading clinical-stage genome editing company developing novel, potentially curative medicines leveraging CRISPR-based technologies.

Trainee Lunch | 12 PM | Dolby Regeneration Medicine Building, Pod C Conference Room (1022)
RSVP to Carmen.Sudduth@ucsf.edu

Seminar | 1:15 PM | HSW303

UCSF welcomes all participants to our events. If you need a reasonable accommodation to participate in this event because of a disability, please contact IRMEvents@ucsf.edu as soon as possible.